Skip to main content
Neil Josephson, MD, Oncology, Seattle, WA, UW Medicine/Harborview Medical Center

NeilCJosephsonMD

Oncology • Seattle, WA

Associate Professor, Medicine, University of Washington School of Medicine

Join to view full profile

Are you Dr. Josephson?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 63 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Neil Josephson, MD is an oncologist in Seattle, Washington. He is currently licensed to practice medicine in Washington, Oregon, and Illinois. He is affiliated with UW Medicine/Harborview Medical Center and UW Medicine/University of Washington Medical Center.

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 1994 - 1998
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1988 - 1991
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1988

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 1991 - Present
  • WA State Medical License
    WA State Medical License 1994 - 2025
  • IL State Medical License
    IL State Medical License 1988 - 1993

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Zymeworks Reports Last Patient Enrolled in Pivotal Study of Zanidatamab in Treatment of HER2-Expressing Late-Line Biliary Tract Cancer
    Zymeworks Reports Last Patient Enrolled in Pivotal Study of Zanidatamab in Treatment of HER2-Expressing Late-Line Biliary Tract CancerApril 28th, 2022
  • Zanidatamab Data Presented at the San Antonio Breast Cancer Symposium (SABCS) Demonstrate Encouraging Antitumor Activity in Heavily Pretreated Patients with HER2-Positive Breast Cancer
    Zanidatamab Data Presented at the San Antonio Breast Cancer Symposium (SABCS) Demonstrate Encouraging Antitumor Activity in Heavily Pretreated Patients with HER2-Positive Breast CancerDecember 8th, 2021
  • Zymeworks Announces Abstract for Zanidatamab in First-Line HER2-Expressing Gastroesophageal Cancers (GEA) at the European Society for Medical Oncology (ESMO) Annual Congress
    Zymeworks Announces Abstract for Zanidatamab in First-Line HER2-Expressing Gastroesophageal Cancers (GEA) at the European Society for Medical Oncology (ESMO) Annual CongressSeptember 12th, 2021
  • Join now to see all

Grant Support

  • Gene Therapy For The Treatment Of CamtNational Heart, Lung, And Blood Institute2005–2009
  • Gene Transfer Into Stem Cells By Foamy Virus VectorsNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2005
  • Gene Transfer Into Stem Cells By Foamy Virus VectorsNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2003
  • Overexpression Of HOXB4 In CAT Hematopoietic CellNational Heart, Lung, And Blood Institute1997–1998

Hospital Affiliations

Dr. Neil Josephson, Dr. Neil Josephson, MD, Dr. N Josephson, Dr. Neil C Josephson